Madrigal Pharmaceuticals, Inc. revenue breakdown overview

Madrigal Pharmaceuticals, Inc. revenue for the last year amounted to 180.13 M USD, the most of which — 180.13 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 147.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Madrigal Pharmaceuticals, Inc. 180.13 M USD, and the year before that — 147.00 k USD.